from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3241c/-

LFCtreatmentdescriptionclass of inhibitor

-0.533

Amikacinug/mL Amikacintranslation

-0.407

Cap5-10ug/mL Capreomycintranslation

-0.388

Rox10-50 ug/mL Roxithromycintranslation

-0.720

SM2-5 ug/mL Streptomycintranslation

-1.237

Tet5-10 ug/mL Tetracyclinetranslation

-1.034

Rif0.2-5ug/mL Rifampicintranscription

-0.366

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.925

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.347

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.402

CPZ10-50 ug/mL Chlorpromazinerespiration

1.200

Clofazimine10-13 ug/mL Clofaziminerespiration

0.369

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.302

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.790

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.020

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.406

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.202

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.461

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.395

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.253

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.061

KCN5-20 ug/mL Potassium cyaniderespiration

0.495

NaN30.2-2 mM Sodium aziderespiration

-0.441

Nigericin50 uM Nigericinrespiration

0.478

TRC10-150 ug/mL Triclosanrespiration

0.727

TRZ10-25 ug/mL Thioridazinerespiration

-2.354

Valinomycin0.5-10 uM Valinomycinrespiration

0.301

ZnSO42 mM ZnSO4respiration

0.223

menadione6-10 ug/mL Menadionerespiration

0.471

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.339

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.075

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.272

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.861

NRP_1Non-replicating persistence stage 1dosRassociated

0.121

Amp0.2mg/mL AmpicillincellWall

-0.221

Cephalexin20-100 ug/mL CephalexincellWall

0.038

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.004

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.443

EMB10-20 ug/mL EthambutolcellWall

1.054

Eta12-40 ug/mL EthionamidecellWall

0.146

INH0.2-0.4 ug/mL IsoniazidcellWall

0.847

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.065

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.454

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.632

BZA0.12 mg/mL BenzamidearomaticAmides

-0.819

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.081

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.846

H2O24 mM hydrogen peroxideDNAdamaging

-0.286

Levo10 ug/mL LevofloxacinDNAdamaging

-0.355

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.962

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.440

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.380

UVUV-irradiationDNAdamaging

0.686

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.623

Antimycin12.5-50 ug/mL Antimycin A?

-0.133

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.619

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.583

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.108

PA8240.2-2 ug/mL PA-824?

-0.537

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.651

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.371

Verapamil50 uM Verapamil?

-0.010

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.279

methoxatin10-20 ug/mL Methoxatin?